CLX Form 4: EVP Eric Reynolds Exercises 15,210 Options and Sells 15,041 Shares

Eric H. Reynolds, Executive Vice President and Chief Operating Officer of The Clorox Company (CLX), reported transactions dated 09/04/2025.

Rhea-AI Filing Summary

Eric H. Reynolds, Executive Vice President and Chief Operating Officer of The Clorox Company (CLX), reported transactions dated 09/04/2025. The filing shows an exercise of stock options (derivative) to acquire 15,210 shares at an exercise/conversion price of $111.60, and a related non-derivative acquisition of 15,210 shares (reported at $111.60). The report also discloses a sale of 15,041 shares at a weighted average price of $123.7848 (trade prices ranged $123.731–$123.84). Following these transactions the reporting person is shown as beneficially owning 69,262 shares after the acquisition and 54,221 shares after the sale. The form is signed by an attorney-in-fact on 09/08/2025.

Insights

Financial Analyst

TL;DR: Insider exercised options and sold a roughly equal blocking of shares the same day, leaving mid-five-figure holdings.

The filing documents a simultaneous option exercise and market sale on 09/04/2025. The exercise converted options covering 15,210 shares at a strike of $111.60, which increased beneficial ownership to 69,262 shares before an executed sale of 15,041 shares at a weighted average of $123.7848. The sale prices ranged narrowly ($123.731–$123.84), indicating execution across multiple trades. For investors, this is a routine Section 16 disclosure showing liquidity-taking after option exercise rather than an unambiguous signal about company fundamentals.

Corporate Governance Expert

TL;DR: Disclosure appears complete for the transactions reported; form is signed by an attorney-in-fact as permitted.

The Form 4 includes required fields: reporting person identity, relationship (EVP & COO), transaction dates, codes, quantities, prices, and an explanatory note on trade price range. The derivative section shows the exercised option details including original exercisability/expiration dates. The signature by an Attorney-in-Fact (Cheryl Brice) on 09/08/2025 is presented. No omissions or inconsistencies are apparent within the form’s content provided.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Reynolds Eric H

Role EVP - Chief Operating Officer

Sold 15,041 shs ($1.86M)

Approx. gross sale proceeds $1.86M

Approx. exercise cost $1.70M

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	15,210	$0.00	$0.00
Exercise	Common Stock	15,210	$111.60	$1.70M
Sale	Common Stock	15,041	$123.7848	$1.86M

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 54,221 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $123.731 to $123.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/08/2025 - 04:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reynolds Eric H

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP - Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2025		M		15,210	A	$111.6	69,262	D
Common Stock	09/04/2025		S		15,041	D	$123.7848(1)	54,221	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$111.6	09/04/2025		M			15,210	09/15/2016	09/15/2025	Common Stock	15,210	$0.0000	0.0000	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $123.731 to $123.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	By Cheryl Brice, Attorney-in-Fact for	09/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.